Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Epilepsia|November 23, 2007
Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsyBruce Hermann, Michael Seidenberg, Mark Sager, et al.Epilepsy Research|March 21, 2024
Lacosamide extended-release capsules are bioequivalent to lacosamide immediate-release tablets: Pharmacokinetic observations and simulationsJames Wheless, Barry Gidal, Lixin Gong, et al.Epilepsy Research|February 8, 2021
Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizuresJohn Hixson, Barry Gidal, Andrei Pikalov, et al.Epilepsy Currents|November 18, 2024
The Multidisciplinary Team in the Treatment of Patients With EpilepsyJohn Stern, Susan Stanton, Laura Howe-Martin, et al.Epilepsy Research|February 19, 2021
Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal sprayM René Bouw, Steve S Chung, Barry Gidal, et al.Epilepsia|October 17, 2023
Patterns of antiseizure medication utilization in the Human Epilepsy ProjectJonah Fox, Sarah Barnard, Shruti H Agashe, et al.Epilepsy Currents|September 23, 2024
Pre- and Post-Exposure Prophylaxis for HIV in Patients Taking Anti-Seizure MedicationsWesley T Kerr, Barry Gidal, Sean N Avedissian, et al.Epilepsia|February 20, 2025
Focal to bilateral tonic-clonic seizures in newly diagnosed focal epilepsyShruti Agashe, Gregory D Cascino, Orrin Devinsky, et al.Epilepsia|July 14, 2022
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 yearsJacqueline A French, Elena Cleary, Dennis Dlugos, et al.Epilepsy Currents|September 27, 2018
Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAndres M Kanner, Eric Ashman, David Gloss, et al.Pageof 4